{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:54:00Z","timestamp":1762552440129,"version":"build-2065373602"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003662","name":"Korea Evaluation Institute of Industrial Technology","doi-asserted-by":"publisher","award":["10077652"],"award-info":[{"award-number":["10077652"]}],"id":[{"id":"10.13039\/501100003662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115335","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T03:20:34Z","timestamp":1754709634000},"page":"115335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["3C3 alleviates atopic dermatitis-like phenotypes through cyclophilin A and B-mediated inhibition of calcineurin-NFAT pathway"],"prefix":"10.1016","volume":"164","author":[{"given":"Yejin","family":"Jo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayan","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jangho","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Heon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soonnam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyoung","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Yoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Sik","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-In","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon-Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bong-Gun","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2025.115335_bb0005","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC phase three","volume":"124","author":"Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI; ISAAC Phase Three Study Group","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0010","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaci.2013.08.031","article-title":"Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study","volume":"132","author":"Silverberg","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115335_bb0015","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.3390\/ijms21082867","article-title":"Skin barrier abnormalities and immune dysfunction in atopic dermatitis","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.115335_bb0020","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jid.2020.07.006","article-title":"Which way do we go? Complex interactions in atopic dermatitis pathogenesis","volume":"141","author":"Patrick","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115335_bb0025","first-page":"1033","article-title":"Chiang BL.J sleep disorders and atopic dermatitis: a 2-way street? Allergy","volume":"142","author":"Chang","year":"2018","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0030","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaci.2022.12.002","article-title":"Comorbidities of atopic dermatitis-what does the evidence say?","volume":"151","author":"Thyssen","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115335_bb0035","article-title":"Advancing treatment in atopic dermatitis: a comprehensive review of clinical efficacy, safety, and comparative insights into corticosteroids, Calcineurin inhibitors, and Phosphodiesterase-4 inhibitors as topical therapies","volume":"16","author":"Hernandez","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.intimp.2025.115335_bb0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin a and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115335_bb0045","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.1073\/pnas.87.23.9231","article-title":"Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin","volume":"87","author":"Bierer","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115335_bb0050","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1002\/j.1460-2075.1990.tb07893.x","article-title":"The actions of cyclosporin a and FK506 suggest a novel step in the activation of T lymphocytes","volume":"9","author":"Mattila","year":"1990","journal-title":"EMBO J."},{"issue":"16","key":"10.1016\/j.intimp.2025.115335_bb0055","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/bi00131a002","article-title":"Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity","volume":"31","author":"Liu","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.intimp.2025.115335_bb0060","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/357692a0","article-title":"FK-506- and CsA-sensitive activation of the interleukin-2 promotor by calcineurin","volume":"357","author":"O\u2019Keefe","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115335_bb0065","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/357695a0","article-title":"Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation","volume":"357","author":"Clipstone","year":"1992","journal-title":"Nature"},{"issue":"4674","key":"10.1016\/j.intimp.2025.115335_bb0070","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.6238408","article-title":"Cyclophilin: a specific cytosolic binding protein for cyclosporin a","volume":"226","author":"Handschumacher","year":"1984","journal-title":"Science"},{"issue":"25","key":"10.1016\/j.intimp.2025.115335_bb0075","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1021\/bi00239a007","article-title":"Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay","volume":"30","author":"Kofron","year":"1991","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.intimp.2025.115335_bb0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.sder.2008.04.004","article-title":"Atopic dermatitis: systemic immunosuppressive therapy","volume":"27","author":"Akhavan","year":"2008","journal-title":"Semin. Cutan. Med. Surg."},{"issue":"6","key":"10.1016\/j.intimp.2025.115335_bb0085","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2014.03.003","article-title":"Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology","volume":"133","author":"Khattri","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115335_bb0090","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jdv.14888","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115335_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/gb-2005-6-7-226","article-title":"The cyclophilins","volume":"6","author":"Wang","year":"2005","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115335_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1094\/PHYTO-05-17-0167-RVW","article-title":"Cyclophilins: less studied proteins with critical roles in pathogenesis","volume":"108","author":"Singh","year":"2018","journal-title":"Phytopathology"},{"issue":"10","key":"10.1016\/j.intimp.2025.115335_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.410","article-title":"Cyclophilin a: a key player for human disease","volume":"4","author":"Nigro","year":"2013","journal-title":"Cell Death Dis."},{"issue":"15","key":"10.1016\/j.intimp.2025.115335_bb0110","doi-asserted-by":"crossref","first-page":"1417945","DOI":"10.3389\/fphar.2024.1417945","article-title":"Cyclophilin inhibition as a strategy for the treatment of human disease","volume":"8","author":"Stauffer","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115335_bb0115","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.bbagen.2014.11.013","article-title":"Extracellular cyclophilins in health and disease","volume":"1850","author":"Bukrinsky","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0120","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.117.310661","article-title":"Extracellular and intracellular Cyclophilin a, native and post-translationally modified, show diverse and specific pathological roles in diseases","volume":"38","author":"Xue","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115335_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096211","article-title":"Cyclophilin a (CypA) interacts with NF-kappaB subunit, p65\/RelA, and contributes to NF-kappaB activation signaling","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0130","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s10753-017-0619-0","article-title":"Cyclophilin a aggravates collagen-induced arthritis via promoting classically activated macrophages","volume":"40","author":"Dongsheng","year":"2017","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.intimp.2025.115335_bb0135","article-title":"Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses","volume":"8","author":"Liu","year":"2017","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.intimp.2025.115335_bb0140","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101044RRR","article-title":"Cyclophilin a is a key positive and negative feedback regulator within interleukin-6 trans-signaling pathway","volume":"35","author":"Luan","year":"2021","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.intimp.2025.115335_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110513","article-title":"Delicate regulation of IL-1\u03b2-mediated inflammation by cyclophilin a","volume":"38","author":"Yang","year":"2022","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.intimp.2025.115335_bb0150","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.ATV.0000130664.51010.28","article-title":"Cyclophilin a is a proinflammatory cytokine that activates endothelial cells","volume":"24","author":"Jin","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115335_bb0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1084\/jem.20101174","article-title":"Cyclophilin a is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice","volume":"208","author":"Nigro","year":"2011","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0160","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/jid.2010.415","article-title":"Keratinocyte secretion of cyclophilin B via the constitutive pathway is regulated through its cyclosporin-binding site","volume":"131","author":"Fearon","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115335_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/cvr\/cvu035","article-title":"Cyclophilin a and EMMPRIN (CD147) in cardiovascular diseases","volume":"102","author":"Seizer","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"2020","key":"10.1016\/j.intimp.2025.115335_bb0170","first-page":"6473858","article-title":"CypB-CD147 signaling is involved in crosstalk between cartilage and FLS in collagen-induced arthritis","volume":"29","author":"Wang","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2025.115335_bb0175","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.3390\/ijms21197160","article-title":"Caffeoyl-prolyl-histidine amide inhibits Fyn and alleviates atopic dermatitis-like phenotypes via suppression of NF-\u039aB activation","volume":"21","author":"Jeong","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115335_bb0180","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.3390\/ijms22126301","article-title":"Synthesis of Caffeoyl-prolyl-Histidyl-Xaa derivatives and evaluation of their activities and stability upon Long-term storage","volume":"22","author":"Jeong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115335_bb0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","article-title":"Drug affinity responsive target stability (DARTS) for small-molecule target identification","volume":"1263","author":"Pai","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"W1","key":"10.1016\/j.intimp.2025.115335_bb0190","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.intimp.2025.115335_bb0195","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.intimp.2025.115335_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.abb.2013.11.010","article-title":"Tryptanthrin ameliorates atopic dermatitis through down-regulation of TSLP","volume":"542","author":"Han","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.intimp.2025.115335_bb0205","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0091-6749(90)90079-J","article-title":"Thymopentin therapy reduces the clinical severity of atopic-dermatitis","volume":"85","author":"Leung","year":"1990","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0210","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jid.2018.11.012","article-title":"Activation of aryl hydrocarbon receptor negatively regulates Thymic stromal Lymphopoietin gene expression via protein kinase C\u03b4-p300-NF-\u03baB pathway in keratinocytes under inflammatory conditions","volume":"139","author":"Jeong","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.115335_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx1188","article-title":"526 JASPAR 2018: update of the open-access database of transcription factor binding profiles and its 527 web framework","volume":"46","author":"Khan","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"43","key":"10.1016\/j.intimp.2025.115335_bb0220","doi-asserted-by":"crossref","first-page":"W39","DOI":"10.1093\/nar\/gkv416","article-title":"The MEME suite","volume":"529","author":"Bailey","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.115335_bb0225","article-title":"Translating translation into patient benefit for atopic eczema","volume":"175 Suppl 2(Suppl Suppl 2):8-12","author":"Reynolds","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115335_bb0230","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch","volume":"155","author":"Wilson","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.115335_bb0235","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.0906-6705.2006.00435.x","article-title":"Glucocorticoid therapy-induced skin atrophy","volume":"15","author":"Schoepe","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2025.115335_bb0240","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40264-015-0287-7","article-title":"Topical corticosteroid-induced skin atrophy: a comprehensive review","volume":"38","author":"Barnes","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.intimp.2025.115335_bb0245","doi-asserted-by":"crossref","first-page":"42","DOI":"10.15252\/emmm.201404601","article-title":"REDD 1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids","volume":"7","author":"Baida","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0250","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jaci.2017.01.039","article-title":"Proteomic analysis of filaggrin deficiency identifies molecular signatures characteristic of atopic eczema","volume":"140","author":"Elias","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2025.115335_bb0255","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/bj3030863","article-title":"Differential expression of cyclophilin isoforms during keratinocyte differentiation","volume":"303","author":"Chatellard-Gruaz","year":"1994","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0260","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1523-1747.2002.01709.x","article-title":"Localization of calcineurin\/NFAT in human skin and psoriasis and inhibition of calcineurin\/NFAT activation in human keratinocytes by cyclosporin a","volume":"118","author":"Al-Daraji","year":"2002","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115335_bb0265","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1073\/pnas.91.11.5183","article-title":"X-ray structure of a cyclophilin B\/cyclosporin complex: comparison with cyclophilin a and delineation of its calcineurin-binding domain","volume":"91","author":"Mikol","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.intimp.2025.115335_bb0270","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1110\/ps.9.12.2386","article-title":"Delineation of the calcineurin-interacting region of cyclophilin B","volume":"9","author":"Carpentier","year":"2000","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115335_bb0275","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1006\/bbrc.2001.5847","article-title":"CD147 is a signaling receptor for cyclophilin B","volume":"288","author":"Yurchenko","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0280","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1073\/pnas.052284899","article-title":"Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix","volume":"99","author":"Allain","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.intimp.2025.115335_bb0285","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4049\/jimmunol.175.1.517","article-title":"Extracellular cyclophilins contribute to the regulation of inflammatory responses","volume":"175","author":"Arora","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115335_bb0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nchembio.1981","article-title":"Cyclophilin a promotes cell migration via the Abl-Crk signaling pathway","volume":"12","author":"Saleh","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0295","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.117.310661","article-title":"Extracellular and intracellular Cyclophilin a, native and post-translationally modified, show diverse and specific pathological roles in diseases","volume":"38","author":"Xue","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115335_bb0300","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nchembio.342","article-title":"Acetylation regulates cyclophilin a catalysis, immunosuppression and HIV isomerization","volume":"6","author":"Lammers","year":"2010","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115335_bb0305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41589-024-01689-z","article-title":"Phospholipid biosynthesis modulates nucleotide metabolism and reductive capacity","volume":"21","author":"Zhu","year":"2025","journal-title":"Nat. Chem. Biol."},{"issue":"19","key":"10.1016\/j.intimp.2025.115335_bb0310","doi-asserted-by":"crossref","first-page":"12037","DOI":"10.1073\/pnas.192206699","article-title":"Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes","volume":"99","author":"Huai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.intimp.2025.115335_bb0315","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/pro.5560010903","article-title":"Active site mutants of human cyclophilin a separate peptidyl-prolyl isomerase activity from cyclosporin a binding and calcineurin inhibition","volume":"1","author":"Zydowsky","year":"1992","journal-title":"Protein Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115335_bb0320","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/0006-291X(91)90404-U","article-title":"A single Trp121 to Ala121 mutation in human cyclophilin alters cyclosporin a affinity and peptidyl-prolyl isomerase activity","volume":"176","author":"Bossard","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2025.115335_bb0325","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1021\/bi00223a003","article-title":"Human and Escherichia coli cyclophilins: sensitivity to inhibition by the immunosuppressant cyclosporin a correlates with a specific tryptophan residue","volume":"30","author":"Liu","year":"1991","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.intimp.2025.115335_bb0330","doi-asserted-by":"crossref","first-page":"21965","DOI":"10.1074\/jbc.M501623200","article-title":"Structure of human cyclophilin a in complex with the novel immunosuppressant sanglifehrin a at 1.6 a resolution","volume":"280","author":"Kallen","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2025.115335_bb0335","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1074\/jbc.C110.181347","article-title":"Cyclophilin a (CyPA) induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147","volume":"286","author":"Song","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.intimp.2025.115335_bb0340","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.1021\/ja020222s","article-title":"The mechanism of cis-trans isomerization of prolyl peptides by cyclophilin","volume":"124","author":"Hur","year":"2002","journal-title":"J. Am. Chem. Soc."},{"issue":"49","key":"10.1016\/j.intimp.2025.115335_bb0345","doi-asserted-by":"crossref","first-page":"15028","DOI":"10.1021\/ja0367851","article-title":"What is so special about Arg 55 in the catalysis of cyclophilin a? Insights from hybrid QM\/MM simulations","volume":"125","author":"Li","year":"2003","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.intimp.2025.115335_bb0350","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nsb975","article-title":"An asymmetric NFAT1 dimer on a pseudo-palindromic kappa B-like DNA site","volume":"10","author":"Jin","year":"2003","journal-title":"Nat. Struct. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115335_bb0355","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nsb981","article-title":"Structure of NFAT1 bound as a dimer to the HIV-1 LTR kappa B element","volume":"10","author":"Giffin","year":"2003","journal-title":"Nat. Struct. Biol."},{"issue":"18","key":"10.1016\/j.intimp.2025.115335_bb0360","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1101\/gad.1102703","article-title":"Transcriptional regulation by calcium, calcineurin, and NFAT","volume":"17","author":"Hogan","year":"2003","journal-title":"Genes Dev."},{"issue":"50","key":"10.1016\/j.intimp.2025.115335_bb0365","doi-asserted-by":"crossref","first-page":"19637","DOI":"10.1073\/pnas.0810648105","article-title":"A dimer-specific function of the transcription factor NFATp","volume":"105","author":"Falvo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"32","key":"10.1016\/j.intimp.2025.115335_bb0370","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1073\/pnas.0812911106","article-title":"NFAT isoforms control activity-dependent muscle fiber type specification","volume":"106","author":"Calabria","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.intimp.2025.115335_bb0375","first-page":"301","article-title":"Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies","volume":"21","author":"Rezzani","year":"2006","journal-title":"Histol. Histopathol."},{"issue":"20","key":"10.1016\/j.intimp.2025.115335_bb0380","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2174\/0929867327666201006153202","article-title":"Cyclosporine a: chemistry and toxicity - a review","volume":"28","author":"Patocka","year":"2021","journal-title":"Curr. Med. Chem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925013268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925013268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:51:44Z","timestamp":1762552304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925013268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":76,"alternative-id":["S1567576925013268"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115335","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3C3 alleviates atopic dermatitis-like phenotypes through cyclophilin A and B-mediated inhibition of calcineurin-NFAT pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115335"}}